Log in to save to my catalogue

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a53af0caadf64c108081ce0c70f541ee

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor

About this item

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Respiratory syncytial virus is a major cause of acute lower respiratory tract infection in young children, immunocompromised adults, and the elderly. Intervention with small-molecule antivirals specific for respiratory syncytial virus presents an important therapeutic opportunity, but no such compounds are approved today. Here we report the structu...

Alternative Titles

Full title

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a53af0caadf64c108081ce0c70f541ee

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a53af0caadf64c108081ce0c70f541ee

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-017-00170-x

How to access this item